Kinetic Concepts, Inc., is a global corporation that produces medical technology related to wounds and wound healing. KCI produced the first product developed specifically for negative pressure wound therapy. As of 2013 the company employs 5,000 people and markets its products in more than 25 countries. Its headquarters is in San Antonio, Texas. Wikipedia.
News Article | December 7, 2016
According to Stratistics MRC, the Regenerative Medicine Market is estimated at $20.07 billion in 2015 and is projected to reach $101.3 billion by 2022 growing at a CAGR of 26.0% from 2015 to 2022. Growing research applications, growing demand in tissue engineering, biomaterials and stem cell therapy systems are some of the factors driving the market growth. However, high cost associated with biomaterials will be a major factor to restrict the market growth. The stem cells application and advancements in nanotechnology will further drive the market over the forecast period. Gene therapies segment is expected to be the fastest emerging technology due to tremendous potential of gene therapy in minimizing immune rejections, which commonly occur after transplantations. Asia-Pacific would be the fastest growing region for regenerative medicine market. Europe and North America together accounted for over 3/4th of the market revenue and anticipated to be most profitable regional market. Some of the key players in the market include Shire Pharmaceuticals, Advanced Cell Technology, Inc, Genzyme, Athersys, Inc., Kinetic Concepts, Inc., NuVasive Inc., Stem cells, Inc., Cytori Therapeutics, Inc., Cytomedix Inc., Mesoblast Ltd. , Zimmer Holdings, Inc., Orthofix, DePuy Synthes Inc., Cell Medica and CryoLife. Regions Covered: • North America o US o Canada o Mexico • Europe o Germany o France o Italy o UK o Spain o Rest of Europe • Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific • Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements For more information, please visit https://www.wiseguyreports.com/sample-request/456590-regenerative-medicine-global-market-outlook-2015-2022
News Article | March 2, 2017
— Market Research Future has a half cooked research report (HCRR) on global Tissue Engineering market which is expected to reach USD 12.6 billion from USD 5.2 billion from 2016 to 2022. Test the market data and market information presented in more than 50 market data tables and figures spread over 80 pages of the project report. Go through the in-depth table of content (TOC) & market synopsis on “Tissue Engineering Market Research Report- Global Forecast to 2022”. Market Highlights: It has been noted that global Tissue Engineering market is growing at rapid pace and is expected to grow tremendously at the CAGR of 22.2%. Globally there is huge demand for Tissue Engineering in various regions. Factors that influence the Tissue Engineering market are increasing technology advancement in healthcare which gives desired results, research area that aims at regenerative alternatives to harvested tissues for transplantation. Moreover increasing development in biological substitutes is influencing the global market for tissue engineering. Tissue engineering is a stimulating research area that aims at regenerative alternatives to collected tissues for transplantation. Biomaterials play a vital role as scaffolds to provide three-dimensional 3D templates and synthetic extracellular-matrix environments for tissue regeneration. It is often beneficial for the scaffolds to mimic certain advantageous characteristics of the natural extracellular matrix, or developmental or would healing programs. Some of the Major players of this market are those that holds the largest market share: • Sanofi (France) • BioMimetic Therapeutics (United States) • StemCellsInc (United States) • Zimmer Biomet (Indiana) • Medtronic (United States) • LifeCell Kinetic Concepts (United States) Other prominent vendors in the market are: • Cook Biotech (United States) • Arteriocyte (United States) • Acelity, Organogenesis (United States) • Athersys (United States) • RTI surgical (United States) • Integra LifeSciences (United States) • Advanced Cell Technology (United States) • CryoLife, (United States) Regional Analysis: Globally North America has the largest share in the tissue engineering market. North America holds about 47% market share for the global tissue engineering market. The share of this nation in this market is mainly due to increasing research and development in tissue engineering. Europe is the second-largest market for Tissue Engineering. Asia Pacific is expected to be fastest growing market for Tissue Engineering. Asia Pacific is expected to be the fastest growing market at a CAGR of 25.5% for the forecasted year from 2016 to 2022. Segmentation: Global Tissue Engineering market has been segmented on the basis of material which includes biomimetic materials synthesis, nano-fibrous materials, composite materials, nano-composite materials and others. Nano-fibrous materials has the largest market share in global Tissue Engineering by material and will be constant in future starting from 2016 lasting till 2022. The main reason for the growth of nano-fibrous material is many extracellular proteins have a fibrous structure with diameters on the nano-meter or sub-micrometer scales. Furthermore on the basis of end-user the market is segmented into Cord Blood & Cell Banking, Cancer, GI & Gynecology, Dental, Skin/Integumentary, Urology, Orthopedics, musculoskeletal and spine, Neurology and Cardiology & Vascular. Orthopedics contribute maximum to the growth of global Tissue Engineering by application due to increased incidence of sports-related injuries, musculoskeletal syndromes have become one of the major health concerns all around the globe. Moreover tissue engineering uses principles of engineering, biology, and chemistry, it provides a more operative approach to the treatment the musculoskeletal disorders than traditional methods. Brief TOC for Tissue Engineering Market: 1 Introduction 1.1 Definition 1.2 Scope of Study 1.3 Research Objective 1.4 Assumptions & Limitations 1.5 Market Structure 2 Research Methodology 2.1 Research Process 2.2 Primary Research 2.3 Secondary Research 3 Market Dynamics 3.1 Drivers 3.2 Restraints 3.3 Opportunities 3.4 Challenges 3.5 Macroeconomic Indicators 4 Market Factor Analysis 4.1 Porter’s five forces model 4.1.1 Bargaining Power of suppliers 4.1.2 Bargaining Power of Customer 4.1.3 Intensity of Competitor’s 4.1.4 Threat of New Entrants 5 Global Tissue Engineering Market, by Device material 5.1 Introduction 5.1.1 Biomimetic Materials Synthesis 5.1.2 Nano-Fibrous Materials 5.1.3 Composite Materials 5.1.4 Nano-Composite Materials Continue... About Market Research Future: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our cooked research report (CRR), half-cooked research reports (HCRR), raw research reports (3R), continuous-feed research (CFR) and market research & consulting services. MRFR team have prime objective to provide top quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end-users and market players for global, regional and country level market segments enables our clients to know more consequently do more, which help them in answering all their most important questions. In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meeting with industry experts and does industrial visits for its research analyst members. For more information, please visit https://www.marketresearchfuture.com/
News Article | November 30, 2016
This report studies Advanced Wound Care in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering 3M Coloplast ConvaTec Kinetic Concepts Molnlycke Health Care Smith & Nephew B. Braun Melsungen C.R. Bard Covidien Derma Sciences Ethicon Paul Hartmann Systagenix Wound Management Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Advanced Wound Care in these regions, from 2011 to 2021 (forecast), like North America Europe China Japan Southeast Asia India Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into Device-based Advanced Wound Care Moist Wound Care Wound Care Biologics Split by application, this report focuses on consumption, market share and growth rate of Advanced Wound Care in each application, can be divided into Application 1 Application 2 Application 3 Global Advanced Wound Care Market Research Report 2016 1 Advanced Wound Care Market Overview 1.1 Product Overview and Scope of Advanced Wound Care 1.2 Advanced Wound Care Segment by Type 1.2.1 Global Production Market Share of Advanced Wound Care by Type in 2015 1.2.2 Device-based Advanced Wound Care 1.2.3 Moist Wound Care 1.2.4 Wound Care Biologics 1.3 Advanced Wound Care Segment by Application 1.3.1 Advanced Wound Care Consumption Market Share by Application in 2015 1.3.2 Application 1 1.3.3 Application 2 1.3.4 Application 3 1.4 Advanced Wound Care Market by Region 1.4.1 North America Status and Prospect (2011-2021) 1.4.2 Europe Status and Prospect (2011-2021) 1.4.3 China Status and Prospect (2011-2021) 1.4.4 Japan Status and Prospect (2011-2021) 1.4.5 Southeast Asia Status and Prospect (2011-2021) 1.4.6 India Status and Prospect (2011-2021) 1.5 Global Market Size (Value) of Advanced Wound Care (2011-2021) 2 Global Advanced Wound Care Market Competition by Manufacturers 2.1 Global Advanced Wound Care Production and Share by Manufacturers (2015 and 2016) 2.2 Global Advanced Wound Care Revenue and Share by Manufacturers (2015 and 2016) 2.3 Global Advanced Wound Care Average Price by Manufacturers (2015 and 2016) 2.4 Manufacturers Advanced Wound Care Manufacturing Base Distribution, Sales Area and Product Type 2.5 Advanced Wound Care Market Competitive Situation and Trends 2.5.1 Advanced Wound Care Market Concentration Rate 2.5.2 Advanced Wound Care Market Share of Top 3 and Top 5 Manufacturers 2.5.3 Mergers & Acquisitions, Expansion 3 Global Advanced Wound Care Production, Revenue (Value) by Region (2011-2016) 3.1 Global Advanced Wound Care Production and Market Share by Region (2011-2016) 3.2 Global Advanced Wound Care Revenue (Value) and Market Share by Region (2011-2016) 3.3 Global Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.4 North America Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.5 Europe Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.6 China Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.7 Japan Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.8 Southeast Asia Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) 3.9 India Advanced Wound Care Production, Revenue, Price and Gross Margin (2011-2016) For more information or any query mail at [email protected]
News Article | December 23, 2016
Dublin, Dec. 23, 2016 (GLOBE NEWSWIRE) -- Research and Markets has announced the addition of the "Advanced Wound Care and Closure Market Analysis & Trends - Product (Active Wound Care, Surgical Wound Care, Infection Management and Therapy Devices), Application (Chronic Wound Care and Acute Wound Care) - Forecast to 2025" report to their offering. Some of the prominent trends that the market is witnessing include increasing funding in wound care and development, rising geriatic population and impetus growth of disorders , increasing volume of surgeries across the globe, recent technological advancements in Advanced Wound Care and Closure, and growth opportunities/investment opportunities. Based on End-User the market is categorized into hospitals & specialty wound clinics, and home healthcare. Further is segmented into inpatient settings and long-term care facilities. Application segment is segregated into chronic wound care, acute wound care, and other applications. Chronic wound care is simultaneously sub-divided into arterial ulcers, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other chronic wounds moreover; acute wound care is sub-divided into burns and surgical & traumatic wounds. Depending on products the market is categorized into active wound care, advanced wound dressings, surgical wound care, infection management, therapy devices, traditional/basic wound care, and other products. This industry report analyzes the global markets for Advanced Wound Care and Closure across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Advanced Wound Care and Closure Market, By End-User 5 Advanced Wound Care and Closure Market, By Application 6 Advanced Wound Care and Closure Market, By Product 6.6 Traditional/Basic wound care 7 Advanced Wound Care and Closure Market, By Geography 8 Key Player Activities 9 Leading Companies - 3M Company - Acelity L.P. Inc. - Alliqua BioMedical, Inc. - BSN Medical GmbH - Baxter International Inc. - Coloplast A/S - Convatec Healthcare B S.À.R.L. - Covidien PLC (A Subsidiary of Medtronic Company) - Derma Sciences,Inc - Ethicon, Inc. - Holdings Corporation - Integra LifeSciences - Kinetic Concepts - Medtronic plc - Mölnlycke Health Care AB - Smith & Nephew PLC For more information about this report visit http://www.researchandmarkets.com/research/pjvn4j/advanced_wound
News Article | November 17, 2016
Research and Markets has announced the addition of the "Advanced Wound Care and Closure Market Analysis & Trends - Product (Active Wound Care, Surgical Wound Care, Infection Management and Therapy Devices), Application (Chronic Wound Care and Acute Wound Care) - Forecast to 2025" report to their offering. Some of the prominent trends that the market is witnessing include increasing funding in wound care and development, rising geriatic population and impetus growth of disorders , increasing volume of surgeries across the globe, recent technological advancements in Advanced Wound Care and Closure, and growth opportunities/investment opportunities. Based on End-User the market is categorized into hospitals & specialty wound clinics, and home healthcare. Further is segmented into inpatient settings and long-term care facilities. Application segment is segregated into chronic wound care, acute wound care, and other applications. Chronic wound care is simultaneously sub-divided into arterial ulcers, diabetic foot ulcers, venous leg ulcers, pressure ulcers, and other chronic wounds moreover; acute wound care is sub-divided into burns and surgical & traumatic wounds. Depending on products the market is categorized into active wound care, advanced wound dressings, surgical wound care, infection management, therapy devices, traditional/basic wound care, and other products. This industry report analyzes the global markets for Advanced Wound Care and Closure across all the given segments on global as well as regional levels presented in the research scope. The study provides historical market data for 2013, 2014 revenue estimations are presented for 2015 and forecasts from 2016 till 2025. The study focuses on market trends, leading players, supply chain trends, technological innovations, key developments, and future strategies. With comprehensive market assessment across the major geographies such as North America, Europe, Asia Pacific, Middle East, Latin America and Rest of the world the report is a valuable asset for the existing players, new entrants and the future investors. Key Topics Covered: 1 Market Outline 2 Executive Summary 3 Market Overview 4 Advanced Wound Care and Closure Market, By End-User 5 Advanced Wound Care and Closure Market, By Application 6 Advanced Wound Care and Closure Market, By Product 6.6 Traditional/Basic wound care 7 Advanced Wound Care and Closure Market, By Geography 8 Key Player Activities 9 Leading Companies - 3M Company - Acelity L.P. Inc. - Alliqua BioMedical, Inc. - BSN Medical GmbH - Baxter International Inc. - Coloplast A/S - Convatec Healthcare B S.À.R.L. - Covidien PLC (A Subsidiary of Medtronic Company) - Derma Sciences,Inc - Ethicon, Inc. - Holdings Corporation - Integra LifeSciences - Kinetic Concepts - Medtronic plc - Mölnlycke Health Care AB - Smith & Nephew PLC For more information about this report visit http://www.researchandmarkets.com/research/l5dg8c/advanced_wound Research and Markets Laura Wood, Senior Manager firstname.lastname@example.org For E.S.T Office Hours Call +1-917-300-0470 For U.S./CAN Toll Free Call +1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 U.S. Fax: 646-607-1907 Fax (outside U.S.): +353-1-481-1716
News Article | December 1, 2016
Advancement in Wound Dressing Market begins years before when the film and hydrocolloids introduced. Advanced Wound Dressing accelerates the healing process by keeping moist environment around the wound along with medicines like antibiotic and painkillers. Advanced Wound Dressing used to heal acute and chronic wounds especially in chronic wounds. Advanced wound dressing has shown very significant results in diabetic patients as well in chronic wounds that takes a long time or cannot be healed by traditional wound dressings. Advanced Wound Dressing market is growing as the number of diabetic and chronic patients increasing rapidly worldwide. Major drivers for the Advanced Wound Dressing Market is ageing population, increase in incident of accidents, increase in adoption rate of Advanced Wound Dressings like hydrocolloids and wound contact layers, continuously advance improvement in dressing like combination of antibiotics and painkillers with dressings. However, high price and lack of adequate reimbursement policies in developing countries are the main hindrance of the market growth. Advance Wound Dressing’s global market is segmented into following types: Advance Wound Dressing Market is growing with a significant CAGR because of its high adoption rate in treatment of chronic wounds. Developing countries is growing with a higher CAGR compared to other parts of the world. Depending on geographic region, global Advanced Wound Dressing market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America contributes maximum in global Wound dressing Market Share. European countries showing a good growth as the adoption rate for Advance Wound Dressing is increasing for diabetic patients, burns, and chronic wounds. Asia Pacific is growing with a significant CAGR for Advance Wound Dressing market due to increase in healthcare awareness. Amongst the Asian countries, India and china are more promising due to large population pool and increased number of hospitals. Key players of Advance Wound Dressing market includes Smith & Nephew, Mölnlycke Health Care, Paul Hartmann, Covidien, ConvaTec, B. Braun Melsungen, BSN medical, 3M Health Care, Systagenix Wound Management, Derma Sciences, Coloplast, Laboratoires Urgo, Johnson & Johnson, Kinetic Concepts, Inc and Others. Local Players also have a significant presence in Advance Wound Dressing Market.
Kinetic Concepts | Date: 2010-07-14
A bariatric treatment system (100) providing a comprehensive array of therapeutic services for the morbidly obese patient (118) is disclosed. The treatment system (100) generally comprises a stable bed frame (101) upon which is mounted a low air loss therapeutic mattress system (104). Integrated hardware and software controls (170) provide such therapies such as pulsation, percussion, rotation, cardiac chair, and Trendelenburg. Means are disclosed whereby the bariatric patient (118) may safely and comfortably enter and exit the bed (100) with relative ease. The bed (100) is adaptable for transport within a hospital, including such features as a TRANSPORT MODE wherein its lateral axis is minimized and battery backup (178) is provided to maintain necessary therapies during patient transport. A plurality of control means are disclosed for simplification of caregiver workload and ease of patient utilization.
News Article | December 21, 2016
Até que a transação seja finalizada, a Acelity continuará a gerenciar os negócios da LifeCell, fornecendo disponibilidade total de produtos e suporte aos cirurgiões. A transação está sujeita à expiração ou término do período de espera previsto na lei de aperfeiçoamento antitruste Hart-Scott-Rodino de 1976 e ao cumprimento de outras condições habituais de fechamento. Na pendência de tais aprovações e do cumprimento de outras condições, a Acelity antecipa o fechamento da transação no primeiro semestre de 2017. A Acelity L.P. Inc. e suas subsidiárias são uma empresa global de tratamento avançado de lesões e medicina regenerativa, criada pela união dos pontos fortes de três empresas: Kinetic Concepts, Inc., LifeCell Corporation e Systagenix Wound Management, Limited. Disponível em mais de 80 países, o portfólio de produtos inovadores e complementares ACELITY™ agrega valor por meio de soluções que aceleram a cura e lideram o setor em qualidade, segurança e experiência do cliente. Sediada em San Antonio, Texas, a Acelity tem mais de 5.800 funcionários no mundo inteiro. O texto no idioma original deste anúncio é a versão oficial autorizada. As traduções são fornecidas apenas como uma facilidade e devem se referir ao texto no idioma original, que é a única versão do texto que tem efeito legal.
News Article | November 18, 2016
Decubitus ulcers commonly occur on the elbows, back of the head, buttocks, heels, shoulders, hips, ankles, and back. Increasing incidences of decubitus ulcers and technological advancements in decubitus ulcer treatment products are some of the major factors driving the decubitus ulcer treatment market. Diagnosis of decubitus ulcer is based on clinical evaluation and nutritional assessment. Treatments for decubitus ulcer include pressure reduction, direct ulcer care, management of pain and control of infection, assessment of nutritional needs, and adjunctive therapy or surgery. Some of the required preventions include identification of high-risk patients, repositioning, conscientious skincare and hygiene, and avoidance of immobilization. On the basis of product, the decubitus ulcer treatment products market can be segmented into air fluidized beds, foam mattresses, alternative air pressure mattresses, low air loss beds, local area support products, and other full support products. Decubitus ulcer or pressure ulcer is an open wound on the skin. Decubitus ulcer occurs due to the breakdown of skin and underlying tissues through excessive pressure on an area of the skin. Some of the symptoms of decubitus ulcer are redness of the skin that worsens with time, and blisters on the area and then an open sore. Increasing incidences of decubitus ulcer, technological advancements, increasing aging population, government initiatives, and development of imagine technologies to enable early detection of ulcer are some of the major factors that are expected to drive the market for decubitus ulcer treatment products. In addition, growing incidences of chronic diseases and rise in awareness regarding the availability of decubitus ulcer treatment products are expected to drive the market for decubitus ulcer treatment products. However, high price of pressure ulcer relief products and economic downturn are some of the major factors restraining the growth of the global decubitus ulcer treatment products market. North America has the largest market for decubitus ulcer treatment products due to largest incidence of pressure ulcer, improved healthcare infrastructure, and technological advancements in this region. The North America decubitus ulcer treatment products market is followed by Europe. Asia is expected to witness high growth rate in the decubitus ulcer treatment products market in the next few years due to increasing demand for improved healthcare facilities, rise in awareness regarding pressure ulcer treatment products, improving healthcare infrastructure, and increasing patient population in the region. Growing population and economies in developing countries such as India and China are expected to drive the growth of the decubitus ulcer treatment products market in Asia. In addition, innovations along with technological advancements, growing awareness regarding decubitus ulcer treatment products, rise in incidences of chronic disorders, and introduction of cost-effective pressure ulcer treatment products are expected to create new opportunities for the global decubitus ulcer treatment products market. Increasing number of mergers and acquisitions, rising number of collaborations and partnerships, and product launches are some of the latest trends in the global decubitus ulcer treatment products market. Some of the major companies operating in the global decubitus ulcer treatment products market are Gaymar Industries, Inc., Invacare Corporation, Sunrise Medical, Inc., Graham-Field Health Products, Inc., and Hill-Rom Company, Inc. In addition, other companies operating in the global decubitus ulcer treatment products market include Spenco Medical, Corp., ROHO, Inc., James Consolidated, Inc., Kinetic Concepts, Inc., and Span-America Medical Systems, Inc.
News Article | December 20, 2016
SAN ANTONIO--(BUSINESS WIRE)--Acelity L.P. today announced a definitive agreement with Allergan for the acquisition of Acelity’s LifeCell business unit for $2.9 billion in cash. Upon completion of the transaction, LifeCell’s industry-leading regenerative medicine and reconstructive surgery portfolio will be combined with Allergan’s leading portfolio of medical aesthetics and breast implants and tissue expanders, enhancing the potential for continued long-term growth of the LifeCell portfolio. The combination will offer Allergan access to a strong commercial channel, robust R&D pipeline and demonstrated manufacturing capability. LifeCell is recognized for applications in plastic and reconstructive surgeries and abdominal wall procedures. The LifeCell portfolio encompasses regenerative and reconstructive acellular tissue matrices for repair of soft tissue defects, as well as autologous fat grafting solutions. Leading products include ALLODERM™ Regenerative Tissue Matrix, a human allograft tissue matrix which allows for a strong, intact repair in breast reconstruction post-mastectomy procedures and other surgical applications, by providing soft tissue reinforcement; and STRATTICE™ Reconstructive Tissue, a porcine based tissue matrix for reinforcement of soft tissue in challenging hernia repair procedures. “This strategic transaction will benefit Acelity and the patients, customers and employees of the LifeCell business,” said Joe Woody, Acelity President and Chief Executive Officer. “The sale of LifeCell to Allergan allows Acelity to continue its transformation with increased momentum and investments that focus on developing and commercializing advanced wound therapies and dressings in markets across the globe.” “The LifeCell brand is renowned in the industry for safety, efficacy and superior clinical results, and the Acelity Board is confident that Allergan will lead it into a strong new phase of growth and development. We are equally excited to continue supporting Acelity as it pursues its quest to enhance advanced wound therapy and improve patients’ lives,” said Buddy Gumina, Chairman of the Acelity Board of Directors. Until the transaction is finalized, Acelity will continue to manage the LifeCell business, providing full product availability and support to surgeons. The transaction is subject to expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and fulfillment of certain other customary conditions to closing. Pending such approvals and fulfillment of other conditions, Acelity anticipates closing the transaction in the first half of 2017. J.P. Morgan Securities LLC and Goldman, Sachs & Co. are serving as financial advisors to Acelity, and Simpson Thacher & Bartlett LLP is serving as Acelity lead legal counsel. Acelity L.P. Inc. and its subsidiaries are a global advanced wound care and regenerative medicine company created by uniting the strengths of three companies, Kinetic Concepts, Inc., LifeCell Corporation and Systagenix Wound Management, Limited. Available in more than 80 countries, the innovative and complementary ACELITY™ product portfolio delivers value through solutions that speed healing and lead the industry in quality, safety and customer experience. Headquartered in San Antonio, Texas, Acelity employs more than 5,800 people around the world.